Bank of America
GNOM icon

Bank of America’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bank of America’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.24M Buy
119,795
+48,394
+68% +$2.24M ﹤0.01% 3427
2025
Q4 		$3.25M Buy
71,401
+34,517
+94% +$1.53M ﹤0.01% 3700
2025
Q3 		$1.43M Buy
36,884
+5,315
+17% +$193K ﹤0.01% 5092
2025
Q2 		$1.06M Sell
31,569
-2,111
-6% -$66.8K ﹤0.01% 5263
2025
Q1 		$1.07M Buy
33,680
+5,578
+20% +$212K ﹤0.01% 5168
2024
Q4 		$1.09M Sell
28,102
-8,638
-24% -$363K ﹤0.01% 4959
2024
Q3 		$1.65M Buy
36,740
+24,347
+196% +$1.09M ﹤0.01% 4707
2024
Q2 		$518K Buy
12,393
+2,374
+24% +$99.2K ﹤0.01% 5321
2024
Q1 		$456K Buy
10,019
+6,113
+157% +$278K ﹤0.01% 5408
2023
Q4 		$181K Buy
3,906
+270
+7% +$11K ﹤0.01% 6118
2023
Q3 		$148K Buy
3,636
+82
+2% +$3.73K ﹤0.01% 6070
2023
Q2 		$172K Sell
3,554
-3,759
-51% -$188K ﹤0.01% 5935
2023
Q1 		$360K Buy
7,313
+541
+8% +$27.8K ﹤0.01% 5586
2022
Q4 		$343K Sell
6,772
-47
-0.7% -$2.42K ﹤0.01% 5631
2022
Q3 		$342K Buy
6,819
+1,493
+28% +$84.3K ﹤0.01% 5650
2022
Q2 		$261K Sell
5,326
-342
-6% -$17.3K ﹤0.01% 5905
2022
Q1 		$341K Sell
5,668
-973
-15% -$61.4K ﹤0.01% 6089
2021
Q4 		$527K Sell
6,641
-10,292
-61% -$865K ﹤0.01% 5811
2021
Q3 		$1.5M Buy
16,933
+11,647
+220% +$1.09M ﹤0.01% 4701
2021
Q2 		$527K Sell
5,286
-5,915
-53% -$525K ﹤0.01% 5383
2021
Q1 		$1.01M Buy
11,201
+10,976
+4,878% +$1.08M ﹤0.01% 4816
2020
Q4 		$22K Buy
+225
New +$18.8K ﹤0.01% 6566

Other funds holding GNOM

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return

Bank of America's GNOM Position: Q1 2026 in Review

Bank of America increased its Global X Genomics & Biotechnology ETF (GNOM) stake by 68% in Q1 2026, buying an estimated $2.24M and bringing the position to 119,795 shares worth $5.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3427.

Bank of America first reported a position in GNOM in Q4 2020 and has held it in 22 quarters since. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

  • Bank of America held 119,795 shares of Global X Genomics & Biotechnology ETF worth $5.24M as of Q1 2026.
  • Bank of America bought 48,394 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $2.24M.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3427 holding.
  • Bank of America first reported a position in Global X Genomics & Biotechnology ETF in Q4 2020 and has held it in 22 quarters since.
  • 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.